Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Capital Expenditures (2020 - 2026)

SkinHealth Systems has reported Capital Expenditures over the past 6 years, most recently at $139000.0 for Q4 2025.

  • Quarterly Capital Expenditures rose 87.84% to $139000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303000.0 through Dec 2025, down 59.92% year-over-year, with the annual reading at $303000.0 for FY2025, 59.92% down from the prior year.
  • Capital Expenditures was $139000.0 for Q4 2025 at SkinHealth Systems, up from $27000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $10.7 million in Q4 2021 and troughed at -$4.2 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $339000.0 (2024), against an average of $1.3 million.
  • The largest YoY upside for Capital Expenditures was 1072.04% in 2021 against a maximum downside of 430.58% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $10.7 million in 2021, then crashed by 90.95% to $967000.0 in 2022, then tumbled by 97.1% to $28000.0 in 2023, then skyrocketed by 164.29% to $74000.0 in 2024, then soared by 87.84% to $139000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Capital Expenditures are $139000.0 (Q4 2025), $27000.0 (Q3 2025), and $92000.0 (Q2 2025).